MedPath

Comparison the effectiveness of carbapenems and piperacillin/tazobactam in treatment of hospitalized cancer patients with fever and neutropenia

Phase 3
Recruiting
Conditions
?Fever and neutropenia in cancer patients.
Neutropenia
Registration Number
IRCT20100127003210N27
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age over 18
Cancer patients with fever (above 38.3 degree) and neutropenia(absolute neutrophil count below 500 per microliter)
Hospitalized patients

Exclusion Criteria

Pregnancy
Unwillingness to participate in the study
Patients with central vein catheter
Prophylactic antibiotic use before starting the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fever above 38.3 degrees Celsius. Timepoint: Every 6 hours a day. Method of measurement: Via mercury thermometer.;Neutrophil count less than 500 per milliliter. Timepoint: Every 24 hours. Method of measurement: 1.Clinical signs and symptoms; 2.Laboratory data.
Secondary Outcome Measures
NameTimeMethod
Hospital length of stay. Timepoint: Daily. Method of measurement: Recording number of hospitalized days.;Duration of neutropenic status. Timepoint: Daily. Method of measurement: Blood Neutrophil count.;Need for other antibiotic consuption. Timepoint: Daily. Method of measurement: Patient's medication list.
© Copyright 2025. All Rights Reserved by MedPath